Clinical Research

Biotech Blogs

Redefining Rare Disease Clinical Research: Inside Takeda’s Patient-Centered, Tech-Driven Approach
Biotech News

FDA’s TEMPO Pilot: Boosting Access to Digital Chronic Disease Tools

How Early Protocol Design Shapes Supply Strategy and RTSM Readiness

February 11, 2026

Decoding Alzheimer’s disease: trial designs, biomarker breakthroughs, and redefining patient-first strategies

February 03, 2026

From FIH to POC — Designing Phase I/Ib Trials with Efficiency

February 25, 2026
Biotech Blogs

UCB’s Camille Lee on Authentic Leadership and Patient-Centered Innovation
Biotech Blogs

Harnessing AI, Patient Voices and Regulatory Pragmatism to Shape the Future of Clinical Research
Biotech Blogs

Advancing Rare Disease Research Through AI, Real-World Evidence and Equity
Biotech Blogs

Reimagining Cell Therapy Through the Untapped Potential of Fibroblasts
Biotech Blogs

Next-Gen Obesity Trials: Redefining Efficacy, Lean Mass and Long-Term Outcomes
Biotech News

Agentic AI Comes to the FDA: A Closer Look at the Rollout

Bridging Bench to Bedside: De-Risking Biotherapeutic Administration via CDMO-Led Clinical-Mimic and In-Use Testing Strategies

January 22, 2026

The Future of Advanced Receptor-Mediated Therapies: Translating Mechanism to Clinical Impact

December 18, 2025

Centralize to Modernize: A Stepwise Path to Agile Clinical Operations

February 10, 2026
Biotech News

Oral Semaglutide Fails to Slow Alzheimer’s Decline in Phase III
Biotech Blogs

Building a Chicago Biotech Hub and Translating Discovery into Impact